Roundtable for Researchers
Scroll Down for Additional Sessions
Grant-Writing Essentials Series:
Part 2 - The Commercialization Plan
July 25, 2019, 12:00 - 1:30 pm EDT
Click to Register
The focus of this session is the all-important commercialization plan. Our experts share commercialization fundamentals to help you visualize the terrain that you will traverse as your product heads toward market and, potentially, patients.
Any private, public, or government funder/investor will expect you to be fluent in these practices. Your credibility is crucial when seeking funding and this discussion will cover a major aspect of your journey.
- Building a Team around your Innovation
- Patent and Market Research
- Prototyping and Scale-Up
- Competitive Insights
- Feasibility of Market Acceptance
- Operationalization Considerations
- Projecting Milestones
- Budget Considerations
About our Speakers:
Director of Business Development and Outreach, Institute of Biotechnology, Cornell University
Marla Coppolino connects researchers in the life sciences to grants, programs, and resources available through New York’s NYSTAR-supported Center for Advanced Technology at Cornell University. Marla serves as a liaison for researchers at Cornell and New York state biotech companies to collaborate on technologies that show potential for future commercialized biotech products and services.
Douglas Greene, MD
Founder and Chief Consultant, DAGPHAMED
Dr. Greene is a highly-respected thought-leader in medicine and drug development, having held numerous executive-level positions in companies such as Ikaria Pharmaceuticals, Sanofi-Aventis, and Merck. Alongside his founding of DAGPHAMED, Dr. Greene is also Partner and Chief Clinical Advisor to Business Stimulus Consultants LLC and Chief Medical Officer of Neuronasal LLC.
Principal Consultant & CEO, 3Sixty Pharma Solutions
Dalfoni Banerjee is an award-winning, solution-focused entrepreneur. Beginning her career over 25 years ago in academic, pharmaceutical, and biotechnology research laboratories, she went on to lead inspection-readiness efforts, drive clinical research and clinical operations, manage relationships between pharma and key opinion leaders, develop marketing strategies/tactics, and launch new drug products – across 12+ therapeutic categories. Dalfoni is an invited speaker and moderator on a variety of topics, has authored and co-authored several publications, and has received over 30 awards.
Grant-Writing Essentials Series
The purpose of this series is to discuss grant-writing experiences for landmark moments on the lab-to-market journey – to show what “good” looks like at key points in the process.
Part 2: The Commercialization Plan • Register Now
Part 1: NIH SBIR/STTR Grant-Writing Best Practices • Recording • PDF
A collaborative session with our Community Partner
3Sixty Pharma Solutions
Bringing together our Roundtable for Researchers
and Young Investigators Programs
Douglas Greene, MD, Founder and Chief Consultant, DAGPHAMED
Dalfoni Banerjee, Principal Consultant & CEO, 3Sixty Pharma Solutions
Understanding the SBIR/STTR landscape,
which crosses every federal agency.
How to “operationalize” the grant-writing process,
enhancing the grant-writer’s prospect for success.